中国学者近期发表的论文
1.	A study of the clinical characteristics and prognosis of advanced mucosal and cutaneous melanoma in a Chinese population. Author: Zhang Y1, Fu X1, Qi Y1, Gao Q1. Journal: Immunotherapy. 2019 Feb;11(2):91-99. doi: 10.2217/imt-2018-0030. Epub 2018 Dec 4.    PubMed      DOI
2.	α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8+ T-cell infiltration. Author: Wang H1, Lin X1, Luo Y1, Sun S1, Tian X1, Sun Y1, Zhang S, Chen J1, Zhang J1, Liu X2, Liu H3, Gong Y4, Xie C1. Journal: Immunotherapy. 2019 Feb;11(2):101-118. doi: 10.2217/imt-2018-0049. Epub 2018 Dec 4.    PubMed      DOI
3.	Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin®-activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancer. Author: Zhao L1, Li T1, Yang Y1, Zhang Y1, Li W1, Han L1, Shang Y, Lin H1, Ren X2, Gao Q1. Journal: Immunotherapy. 2019 Mar;11(4):273-282. doi: 10.2217/imt-2018-0147. Epub 2018 Dec 14.    PubMed      DOI
4.	Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy. Author: Li Q1, Huang J1, Ou Y1, Li Y1, Wu Y1. Journal: Immunotherapy. 2019 Mar;11(4):265-272. doi: 10.2217/imt-2018-0083. Epub 2019 Jan 4.    PubMed      DOI
5.	Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritis. Author: Zhang Z1, Deng W2, Wu Q2, Sun L1. Journal: Immunotherapy. 2019 Mar;11(4):321-333. doi: 10.2217/imt-2018-0113. Epub 2019 Jan 11.    PubMed      DOI
6.	First-line checkpoint inhibitors for wild-type advanced non-small-cell cancer: a pair-wise and network meta-analysis. Author: Wang XJ1, Lin JZ2, Yu SH3, Wu SX4, Luo HS4, Du ZS5, Li XY3. Journal: Immunotherapy. 2019 Mar;11(4):311-320. doi: 10.2217/imt-2018-0107.    PubMed      DOI
7.	Intestinal microbiota predicts lung cancer patients at risk of immune-related diarrhea. Author: Liu T1, Xiong Q1, Li L1, Hu Y1. Journal: Immunotherapy. 2019 Apr;11(5):385-396. doi: 10.2217/imt-2018-0144. Epub 2019 Jan 29.    PubMed      DOI
8.	Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action. Author: Zhang N1, Tu J2, Wang X1, Chu Q2. Journal: Immunotherapy. 2019 Apr;11(5):429-441. doi: 10.2217/imt-2018-0110. Epub 2019 Jan 30.    PubMed      DOI
9.	Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantation. Author: Liu J1, Zhang X1, Zhong JF2, Zhang C1. Journal: Immunotherapy. 2019 Jan;11(1):37-44. doi: 10.2217/imt-2018-0089.    PubMed      DOI
10.	Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy. Author: Song Y1,2, Li Z1,2, Xue W1,2, Zhang M1,2. Journal: Immunotherapy. 2019 Apr;11(6):515-529. doi: 10.2217/imt-2018-0173.    PubMed      DOI

同类著名期刊名称 h-index CiteScore NATURE REVIEWS IMMUNOLOGY 351 18.05 IMMUNITY 355 14.69 NATURE IMMUNOLOGY 344 14.71 Annual Review of Immunology 279 23.62 IMMUNOLOGICAL REVIEWS 197 10.10 TRENDS IN IMMUNOLOGY 209 10.82 JOURNAL OF EXPERIMENTAL MEDICINE 411 9.83 SEMINARS IN IMMUNOLOGY 114 6.96 Cellular & Molecular Immunology 64 5.23 AUTOIMMUNITY REVIEWS 103 7.50

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 292479 CANCER RESEARCH 164273 Molecular Medicine Reports 162837 International Journal of Nanomedicine 162827 CANCER LETTERS 157892 JOURNAL OF ETHNOPHARMACOLOGY 139838 BIOMEDICINE & PHARMACOTHERAPY 138178 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 134438 Theranostics 133806 International Journal of Environmental Research and Public Health 132005